These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12444210)

  • 1. Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.
    Lin SL; Chen YM; Chien CT; Chiang WC; Tsai CC; Tsai TJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2916-29. PubMed ID: 12444210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats.
    Aoyama I; Shimokata K; Niwa T
    Nephron; 2002 Mar; 90(3):297-312. PubMed ID: 11867951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofibroblast phenotypes expression in experimental renal scarring.
    Muchaneta-Kubara EC; el Nahas AM
    Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis.
    Asai M; Monkawa T; Marumo T; Fukuda S; Tsuji M; Yoshino J; Kawachi H; Shimizu F; Hayashi M; Saruta T
    Hypertens Res; 2004 Dec; 27(12):971-8. PubMed ID: 15894838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
    Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
    Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.
    Kang DH; Yu ES; Yoon KI; Johnson R
    Am J Pathol; 2004 Feb; 164(2):679-88. PubMed ID: 14742271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney.
    Yang N; Wu LL; Nikolic-Paterson DJ; Ng YY; Yang WC; Mu W; Gilbert RE; Cooper ME; Atkins RC; Lan HY
    Nephrol Dial Transplant; 1998 Aug; 13(8):1967-74. PubMed ID: 9719149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effect of pentoxifylline in advanced chronic kidney disease.
    Kao CC; Wu MS
    J Formos Med Assoc; 2015 Jan; 114(1):94. PubMed ID: 24974130
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained plasma fibrinogen elevation in subtotal nephrectomized rats: effect of cilazapril, an angiotensin-converting enzyme inhibitor.
    Sugimoto K; Tsuruoka S; Fujimura A
    J Pharmacol Sci; 2004 Jan; 94(1):67-72. PubMed ID: 14745120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline: a potential therapy for chronic kidney disease.
    Lin SL; Chen YM; Chiang WC; Tsai TJ; Chen WY
    Nephrology (Carlton); 2004 Aug; 9(4):198-204. PubMed ID: 15363050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
    Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kangxianling decoction prevents renal fibrosis in rats with 5/6 nephrectomy and inhibits Ang II-induced ECM production in glomerular mesangial cells.
    Ji J; Tao P; He L
    J Pharmacol Sci; 2019 Apr; 139(4):367-372. PubMed ID: 30929858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.